Sort   by:  
 Page size 
UnknownXPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.
Not available
S-EPMC7641823 | biostudies-literature
UnknownMassively parallel de novo protein design for targeted therapeutics.
Not available
S-EPMC5802399 | biostudies-literature
UnknownAfatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial.
Not available
S-EPMC5391700 | biostudies-literature
UnknownAnalysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.
Not available
S-EPMC4806328 | biostudies-literature
Unknown2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Not available
S-EPMC10718225 | biostudies-literature
UnknownGeocultural differences in preschooler sleep profiles and family practices: an analysis of pooled data from 37 countries.
Not available
S-EPMC11985386 | biostudies-literature
UnknownFirst-Line Selpercatinib or Chemotherapy and Pembrolizumab in <i>RET</i> Fusion-Positive NSCLC.
Not available
S-EPMC10698285 | biostudies-literature
UnknownThe electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.
Not available
S-EPMC12144291 | biostudies-literature
UnknownUltrahigh-energy gamma-ray emission associated with black hole-jet systems.
Not available
S-EPMC12746838 | biostudies-literature
UnknownLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060 | biostudies-literature
Sort   by:  
 Page size